We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$472M
AUM Growth
-$53.2M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
37.41%
Holding
149
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 21.74%
2 Real Estate 12.26%
3 Technology 11.11%
4 Energy 9.46%
5 Financials 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRSP icon
26
CRISPR Therapeutics
CRSP
$5.17B
– –
0
– –
ADC icon
27
Agree Realty
ADC
$9.41B
– –
0
– –
PETQ
28
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
– –
0
– –
SKY icon
29
Champion Homes
SKY
$5.14B
– –
0
– –
ZLAB icon
30
Zai Lab
ZLAB
$2.62B
– –
0
– –
EB
31
DELISTED
Eventbrite
EB
– –
0
– –
EVOP
32
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
– –
0
– –
SPAQ.U
33
DELISTED
Spartan Energy Acquisition Corp Units (each consisting of one Class A Common Stock and one-third of
SPAQ.U
– –
0
– –
TLYS icon
34
Tilly's
TLYS
$128M
– –
0
– –
VKTX icon
35
Viking Therapeutics
VKTX
$4B
– –
0
– –
RNST icon
36
Renasant Corp
RNST
$3.91B
– –
0
– –
ECYT
37
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
0
– –
FND icon
38
Floor & Decor
FND
$6.68B
– –
0
– –
IIN
39
DELISTED
IntriCon Corporation
IIN
– –
0
– –
DRNA
40
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
0
– –
TSLX icon
41
Sixth Street Specialty
TSLX
$1.81B
– –
0
– –
SAGE
42
DELISTED
Sage Therapeutics
SAGE
– –
0
– –
VTAK icon
43
Catheter Precision
VTAK
$1.01M
– –
0
– –
PGTI
44
DELISTED
PGT, Inc.
PGTI
– –
0
– –
NXEOW
45
DELISTED
Nexeo Solutions, Inc. Warrant
NXEOW
– –
0
– –
FATE icon
46
Fate Therapeutics
FATE
$326M
– –
0
– –
CLPR
47
Clipper Realty
CLPR
$46.2M
– –
0
– –
FSCT
48
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
– –
0
– –
USAC icon
49
USA Compression Partners
USAC
$3.74B
– –
0
– –
RP
50
DELISTED
RealPage, Inc.
RP
– –
0
– –
1
2
3 4 5

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q3 2018 Portfolio in Review

As of Q3 2018, Monashee Investment Management held 149 positions worth $472M, down 10% from $525M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 0%. Monashee Investment Management opened no new positions and made no exits, leaving the 149-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Real Estate and Technology.

  • Monashee Investment Management's ten largest holdings make up 37% of its $472M portfolio in Q3 2018.
  • Monashee Investment Management opened 0 new positions and closed 0 in Q3 2018.
  • Monashee Investment Management's portfolio value fell 10% quarter-over-quarter to $472M.

Based on Monashee Investment Management's 13F filing for Q3 2018, filed 13 Nov 2018.